Source: Virtual Congress 2021 – Transforming respiratory care: why now is the time to act



Rating:

Share or cite this content

Citations should be made in the following way:
M. Humbert (Le Kremlin-Bicêtre, France), T. Winders (Hendersonville, United States of America), P. Panella (Gerrards Cross, United Kingdom), C. Jenkins (McMahons Point (NSW), Australia), J. Hurst (London, United Kingdom), J. Chorostowska-Wynimko (Warsaw, Poland). Panel discussion: elevating respiratory diseases to the top of the political agenda. Virtual Congress 2021 – Transforming respiratory care: why now is the time to act

Member's Comments

No comment yet.

Related content which might interest you: Raising the political agenda of respiratory disease Source: Annual Congress 2007 - Primary care: from the patient to the politics Year: 2007 Mitigation of occupational respiratory diseases: role of regional respiratory societies and policies in clinical practice and education Source: International Congress 2016 – Occupational lung disease worldwide Year: 2016 Paediatric respiratory training in Europe: political, educational and historical perspective Source: Breathe 2009; 5: 374-383 Year: 2009 Breathe: exploring local and global issues in respiratory health Source: Breathe 2016; 12: 199-200 Year: 2016 Crowdfunding for respiratory research: a new frontier for patient and public engagement? Source: Eur Respir J, 50 (4) 1701333; 10.1183/13993003.01333-2017 Year: 2017 Keeping health on the political agenda Source: Eur Respir J 2015; 45: 608-609 Year: 2015 Research priorities in chronic breathlessness: international expert consensus Source: International Congress 2019 – Hot topics in assessment and care for chronic lung diseases Year: 2019 Challenges raised by COVID in early career respiratory professional training - moderated discussion Source: Virtual Congress 2021 – Challenges raised by COVID in early career respiratory professional training Year: 2021 Asthma research in Europe: a transformative agenda for innovation and competitiveness Source: Eur Respir J, 49 (5) 1602294; 10.1183/13993003.02294-2016 Year: 2017 Implementation of personalized treatment of asthma by improved phenotyping: Critical review of knowledge gaps and unmet research needs by the European asthma research & innovation partnership (EARIP) expert panel Source: International Congress 2016 – Phenotyping asthma Year: 2016 Patient involvement in agenda setting for respiratory research in the Netherlands Source: Eur Respir J 2012; 40: 508-510 Year: 2012 The IMCA project: achievements and new challenges in monitoring respiratory diseases in Europe Source: Annual Congress 2010 - Monitoring chronic respiratory diseases in Europe: what we know, new challenges and new opportunities Year: 2010 Translating scientific discoveries during pandemics: ensuring equity for people affected by COVID-19 and tuberculosis Source: ERJ Open Res, 6 (4) 00562-2020; 10.1183/23120541.00562-2020 Year: 2020 Influencing policy makers about respiratory disease Source: Annual Congress 2013 –ERS White Book of Respiratory Medicine in Europe 2013 Year: 2013 The management of work-related asthma guidelines: a broader perspective Source: Eur Respir Rev 2012; 21: 125-139 Year: 2012 The new WHO air quality guidelines: policy and clinical implications for children with respiratory diseases Source: Virtual Congress 2021 – The environment and climate change effects on lung health across the lifecourse Year: 2021 Formulating recommendations and identifying areas of future research - Panel discussion and protocol Source: Research Seminar 2009 - The rationale and use of surfactant and continuous positive airway pressure (CPAP) in extremely low gestational age neonates (ELGANs) Year: 2009